Document Classification

Section Type: RESULTS

Text: After 12-week treatment, fasting glucose (110. 1 + / - 9. 9 to 98. 9 + / - 15. 7 mg/dl, P <. 001), fasting insulin (11. 6 + / - 5. 4 to 8. 8 + / - 3. 5 mU/L, P =. 05), fasting C-peptide (2. 5 + / - 0. 7 to 1. 8 + / - 0. 5 ng/mL, P <. 05), and achieved C-peptide (5. 2 + / - 1. 2 to 4. 2 + / - 1 ng/mL, P <. 05) levels decreased in the metformin group.